Infectious Disease Reports
Infectious Disease Market Size and Performance
BioPortfolio.net provides an extensive range of infectious disease market research reports showing global and national market data for vaccines, drugs, medicines and treatments for infectious diseases. Reports include market performance, and trends, key corporate information, future predictions and past activity in the infectious disease sector.
Latest Infectious Disease Market Research Reports
BioPortfolio lists the most up to date infectious disease market reports from over 30 leading market research companies for immediate purchase using our SECURE payment system. You can buy the latest infectious disease reports immediately online now.
We list Infectious Disease Mergers and Acquisition reports for the infectious disease market, for the major pharmaceutical and biotech companies in this sector.
There are also reports on the Global Infectious Disease Market and Infectious Disease Research as well as for markets for specific infectious diseases including: tuberculosis market research, influenza (flu) market research and hiv-aids market research.
What is infectious disease?
Infectious diseases, also known as contagious diseases or transmissible diseases, and include communicable diseases, comprise clinically evident illness (i.e., characteristic medical signs and/or symptoms of disease) resulting from the infection, presence and growth of pathogenic biological agents in an individual host organism. In certain cases, infectious diseases may be asymptomatic for much or all of their course. Infectious pathogens include some viruses, bacteria, fungi, protozoa, multicellular parasites, and aberrant proteins known as prions. These pathogens are the cause of disease epidemics, in the sense that without the pathogen, no infectious epidemic occurs.Transmission of pathogen can occur in various ways including physical contact, contaminated food, body fluids, objects, airborne inhalation, or through vector organisms. Infectious diseases that are especially infective are sometimes called contagious and can be easily transmitted by contact with an ill person.
Current Infectious Disease News
The latest infectious disease news from around the world is also available on the infectious diseases news pages of our sister site BioPortfolio.com
Leading Infectious Disease Market Research Reports
Here is our current list of market research reports about infectious diseases.
Other Infectious Diseases – Pipeline Review, H2 2012 published last year by Global Markets Direct …of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Other Infectious Diseases, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Other Infectious Diseases. Other Infectious Diseases - Pipeline Review, Half… | Buy nowMore info | |
Global Infectious Disease Treatment Market 2011-2014 published last year by Infiniti Research (Technavio) TechNavio’s analysts forecast the Global Infectious Disease Treatment market to grow at a CAGR of 8.1 percent over the period 2011–2014. One of the key factors contributing to this market growth is the increase in prevalence of infectious diseases. The Global Infectious Disease Treatment market has also been witnessing mergers… | Buy nowMore info | |
PharmaPoint: Hepatitis C Virus - China Drug Forecast and Market Analysis published last month by GlobalData …has released its new Country report, “PharmaPoint: Hepatitis C Virus - China Drug Forecast and Market Analysis”. Hepatitis C is a liver infection caused by the hepatitis C virus (HCV) that results in acute or chronic presentation. The disease is often asymptomatic, but infected patients may experience fatigue, joint pain… | Buy nowMore info | |
PharmaPoint: Hepatitis C Virus - Brazil Drug Forecast and Market Analysis published last month by GlobalData …has released its new Country report, “PharmaPoint: Hepatitis C Virus - Brazil Drug Forecast and Market Analysis”. Hepatitis C is a liver infection caused by the hepatitis C virus (HCV) that results in acute or chronic presentation. The disease is often asymptomatic, but infected patients may experience fatigue, joint pain… | Buy nowMore info | |
PharmaPoint: Hepatitis C Virus - Japan Drug Forecast and Market Analysis published last month by GlobalData …has released its new Country report, “PharmaPoint: Hepatitis C Virus - Japan Drug Forecast and Market Analysis”. Hepatitis C is a liver infection caused by the hepatitis C virus (HCV) that results in acute or chronic presentation. The disease is often asymptomatic, but infected patients may experience fatigue, joint pain… | Buy nowMore info | |
PharmaPoint: Hepatitis C Virus - United Kingdom Drug Forecast and Market Analysis published last month by GlobalData …has released its new Country report, “PharmaPoint: Hepatitis C Virus - United Kingdom Drug Forecast and Market Analysis”. Hepatitis C is a liver infection caused by the hepatitis C virus (HCV) that results in acute or chronic presentation. The disease is often asymptomatic, but infected patients may experience fatigue, joint… | Buy nowMore info | |
PharmaPoint: Hepatitis C Virus - Spain Drug Forecast and Market Analysis published last month by GlobalData …has released its new Country report, “PharmaPoint: Hepatitis C Virus - Spain Drug Forecast and Market Analysis”. Hepatitis C is a liver infection caused by the hepatitis C virus (HCV) that results in acute or chronic presentation. The disease is often asymptomatic, but infected patients may experience fatigue, joint pain… | Buy nowMore info | |
PharmaPoint: Hepatitis C Virus - Italy Drug Forecast and Market Analysis published last month by GlobalData …has released its new Country report, “PharmaPoint: Hepatitis C Virus - Italy Drug Forecast and Market Analysis”. Hepatitis C is a liver infection caused by the hepatitis C virus (HCV) that results in acute or chronic presentation. The disease is often asymptomatic, but infected patients may experience fatigue, joint pain… | Buy nowMore info | |
PharmaPoint: Hepatitis C Virus - Germany Drug Forecast and Market Analysis published last month by GlobalData …has released its new Country report, “PharmaPoint: Hepatitis C Virus - Germany Drug Forecast and Market Analysis”. Hepatitis C is a liver infection caused by the hepatitis C virus (HCV) that results in acute or chronic presentation. The disease is often asymptomatic, but infected patients may experience fatigue, joint pain… | Buy nowMore info | |
PharmaPoint: Hepatitis C Virus - France Drug Forecast and Market Analysis published last month by GlobalData …has released its new Country report, “PharmaPoint: Hepatitis C Virus - France Drug Forecast and Market Analysis”. Hepatitis C is a liver infection caused by the hepatitis C virus (HCV) that results in acute or chronic presentation. The disease is often asymptomatic, but infected patients may experience fatigue, joint pain… | Buy nowMore info | |
PharmaPoint: Hepatitis C Virus - United States Drug Forecast and Market Analysis published last month by GlobalData …has released its new Country report, “PharmaPoint: Hepatitis C Virus - United States Drug Forecast and Market Analysis”. Hepatitis C is a liver infection caused by the hepatitis C virus (HCV) that results in acute or chronic presentation. The disease is often asymptomatic, but infected patients may experience fatigue, joint… | Buy nowMore info | |
PharmaPoint: Hepatitis C Virus - Current and Future Players published last month by GlobalData …has released its pharma report, “PharmaPoint: Hepatitis C Virus - Current and Future Players”. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing HCV Market. The report identifies and analyses the key companies shaping and driving the global HCV market… | Buy nowMore info | |
Vaginitis – Pipeline Review, H1 2013 published last month by Global Markets Direct …of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Vaginitis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Vaginitis. Vaginitis - Pipeline Review, Half Year is built using data and… | Buy nowMore info | |
High-Grade Glioma – Pipeline Review, H1 2013 published last month by Global Markets Direct …of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for High-Grade Glioma, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for High-Grade Glioma. High-Grade Glioma - Pipeline Review, Half Year is built… | Buy nowMore info | |
Bone Fracture – Pipeline Review, H1 2013 published last month by Global Markets Direct …of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Bone Fracture, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Bone Fracture. Bone Fracture - Pipeline Review, Half Year is built… | Buy nowMore info | |
Dental Pain – Pipeline Review, H1 2013 published last month by Global Markets Direct …of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Dental Pain, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Dental Pain. Dental Pain - Pipeline Review, Half Year is built… | Buy nowMore info | |
Sjogren's Syndrome – Pipeline Review, H1 2013 published last month by Global Markets Direct …of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Sjogren's Syndrome, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Sjogren's Syndrome. Sjogren's Syndrome - Pipeline Review, Half Year is built… | Buy nowMore info | |
Neurofibromatoses – Pipeline Review, H1 2013 published last month by Global Markets Direct …of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Neurofibromatoses, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Neurofibromatoses. Neurofibromatoses - Pipeline Review, Half Year is built using data and… | Buy nowMore info | |
Birch Pollen Allergy – Pipeline Review, H1 2013 published last month by Global Markets Direct …of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Birch Pollen Allergy, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Birch Pollen Allergy. Birch Pollen Allergy - Pipeline Review, Half… | Buy nowMore info | |
Myasthenia Gravis – Pipeline Review, H1 2013 published last month by Global Markets Direct …of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Myasthenia Gravis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Myasthenia Gravis. Myasthenia Gravis - Pipeline Review, Half Year is built… | Buy nowMore info | |
Chlamydia Infections – Pipeline Review, H1 2013 published last month by Global Markets Direct …of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Chlamydia Infections, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Chlamydia Infections. Chlamydia Infections - Pipeline Review, Half Year is built… | Buy nowMore info | |
Acinetobacter Infections – Pipeline Review, H1 2013 published last month by Global Markets Direct …of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Acinetobacter Infections, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Acinetobacter Infections. Acinetobacter Infections - Pipeline Review, Half Year is built… | Buy nowMore info | |
Anthrax – Pipeline Review, H1 2013 published last month by Global Markets Direct …of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Anthrax, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Anthrax. Anthrax - Pipeline Review, Half Year is built using data and… | Buy nowMore info | |
Hepatitis B – Pipeline Review, H1 2013 published last month by Global Markets Direct …of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Hepatitis B, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Hepatitis B. Hepatitis B - Pipeline Review, Half Year is built… | Buy nowMore info | |
PharmaPoint: Seasonal Influenza Vaccines United States Drug Forecast and Market Analysis (Discount Price) published last year by GlobalData | Buy nowMore info |
You are searching within Infectious Disease reports.